ELIGO BIOSCIENCE

THE MICROBIOME COMPANY

From lab to startup

Eligo Bioscience was created in 2014 based on the research from the Lu Lab (MIT) and the Marraffini Lab (Rockefeller University), which was later published in Nature Biotechnology.
Eligo was incubated at the Institut Pasteur in Paris from 2014 to 2017 and has moved in 2017 into the biotech cluster “Paris Biotech Santé” in the Cochin Hospital..

Our founders

Dr. David Bikard

• Tenure-track Professor at Institut Pasteur, Synthetic Biology Laboratory
• Travey K. Lee Award
• Bettencourt-Schuller Young Scientist Award

Dr. Xavier Duportet

• Former INRIA & MIT PhD student
• Kairos 50, MIT TR35, French Innovator of the Year
• Young Global Leader, WEF
• Forbes 30 Under 30 in Science & Healthcare

Prof. Timothy Lu, MD-PhD

• Associate Professor of Biological Engineering, Electrical Engineering, and Computer Science at MIT
• Cofounder Synlogic & Sample6
• NIH New Innovator Award, MIT TR35
• Presidential Early Career Award

Prof. Luciano Marraffini

• Associate Professor at Rockefeller University, Laboratory of Bacteriology
• Cofounder Intellia Therapeutics
• CRISPR seminal inventor
• NIH New Innovator Award
• Cell 40 Under 40, Blavatnik National Award

Our Awards & Grants

A strong international
and interdisciplinary team

We have assembled a team of extremely talented and experienced scientists and executives from the best institutions worldwide to translate our research into useful products.

A strong international
and interdisciplinary team

We have assembled a team of extremely talented and experienced scientists and executives from the best institutions worldwide to translate our research into useful products.

Meet our team

Xavier Duportet, PhD
—
CEO

David Bikard, PhD
—
CSO

Matthieu Galtier, PhD
—
Head – Animal Models

Jesus Fernandez-Rodriguez, PhD
—
Head – Synthetic Biology

Antoine Decrulle, PhD
—
Head – Synthetic Biology

Erica Lieberman, BSc
—
Head – Discovery & Automation

Igor Stzepourginski, PhD
—
Head – Preclinical Ops

Antonina Krawczyk, PhD
—
Synthetic Biology

Daniel Garry, PhD
—
Synthetic Biology

Marion Arraou, Msc
—
Synthetic Biology

Benjamin Buhot
—
Discovery & Automation

Michèle Paquier, MSc
—
Head – Intellectual Property

Loic Charpenay
—
Animal models

Rémi Terrasse, PhD
—
Synthetic Biology

Agnese De Iure
—
Legal

Miriam Gomez Dorado, PhD
—
Lab Manager

Fabien Fuche, PhD
—
Animal models

Camila Bramorski
—
Synthetic Biology

Simone Pignotti, MSc
—
Bioinformatics

Gautier Prévot, Msc
—
Synthetic Biology

Dalila Spadoni, MSc
—
Formulation & Animal Models

Aymeric Leveau, PhD
—
Anaerobes Engineering

Aurélie Mathieu, PhD
—
Anaerobes Engineering

Ines Canadas Blasco, PhD
—
Anaerobes Engineering

Chloé Poquet
—
In-vivo models

Olivier Kerbarh, PhD
—
CMC

Aurélie Grienenberger, PhD
—
Chief Business Officer

Marie Rouquette, PhD
—
Dev & Regulatory

Ruth Keary, PhD
—
Synthetic Biology

Zack Hobbs, BSc
—
Automation & Discovery

Andreas Brodel, PhD
—
Synthetic Biology

Mariangela Malerba, PhD
—
In-vivo models

Thibault Carlier
—
Synthetic Biology

Dora Weides
—
Office Manager

Sfia Ourabat
—
Lab technician

Agathe Peyrottes
—
BD associate

Victor Pabst
—
Research engineer

Hugo Ombredane
—
Research engineer

Gaelle Jan
—
IP

Kristin Muench
—
Research Scientist

Meet our investors

Seventure Partners

With over €600m in assets under management as of the end of 2015, Seventure Partners is a leading venture capital firm in Europe. Since 1997, Seventure Partners has invested in innovative businesses with high growth potential in the life sciences field across Europe and North America, and in digital technologies in France and Germany.

Khosla Ventures

Khosla Ventures is an American venture capital firm focused on early stage companies in the Internet, computing, mobile, silicon technology, biotechnology, healthcare and clean technology sectors that were founded by Vinod Khosla.[1][2]The firm is based in Menlo Park, California, and manages approximately $1.3 billion of investor capital as well as earlier funds funded by Khosla.

Meet our investors

Seventure Partners

With over €600m in assets under management as of the end of 2015, Seventure Partners is a leading venture capital firm in Europe. Since 1997, Seventure Partners has invested in innovative businesses with high growth potential in the life sciences field across Europe and North America, and in digital technologies in France and Germany.

Khosla Ventures

Khosla Ventures is an American venture capital firm focused on early stage companies in the Internet, computing, mobile, silicon technology, biotechnology, healthcare and clean technology sectors that were founded by Vinod Khosla.[1][2]The firm is based in Menlo Park, California, and manages approximately $1.3 billion of investor capital as well as earlier funds funded by Khosla.

From lab to startup

Our founders

Dr. David Bikard

Dr. Xavier Duportet

Prof. Timothy Lu, MD-PhD

Prof. Luciano Marraffini

Our Awards & Grants

A strong international and interdisciplinary team

A strong international and interdisciplinary team

Meet our team

Meet our investors

Meet our investors

A strong international
and interdisciplinary team

A strong international
and interdisciplinary team